When HPV Clears on Its Own, and When It Doesn't

Does HPV go away on its own?

Yes, in most cases. The majority of HPV infections are cleared by the immune system within one to two years without ever causing a symptom, and most people who acquire HPV never know they were infected at all 1Ref 1Centers for Disease Control and Prevention (2024).Human Papillomavirus (HPV).Supports that HPV is the most common STI in the U.S., that most infections clear on their own, and that persistent high-risk-type infection can progress to cancer.. A smaller share of infections persist beyond that window, and it's the persistent ones — not the ones that clear — that carry the risk clinicians actually watch for.

HPV is the most common sexually transmitted infection in the country, largely because clearance is the typical outcome and new exposure is common across a lifetime of sexual activity 1Ref 1Centers for Disease Control and Prevention (2024).Human Papillomavirus (HPV).Supports that HPV is the most common STI in the U.S., that most infections clear on their own, and that persistent high-risk-type infection can progress to cancer.. The virus becoming undetectable is the ordinary story here, not the exception.

Why do some infections clear and others don't?

There is no reliable way to predict, for any single infection, whether it will clear or persist over the next year or two — clearance is controlled by the immune system, not by anything a person does differently. What is known is that persistence is what matters clinically: an infection with a high-risk HPV type that fails to clear is the pathway linked to cervical and other HPV-related cancers over time 1Ref 1Centers for Disease Control and Prevention (2024).Human Papillomavirus (HPV).Supports that HPV is the most common STI in the U.S., that most infections clear on their own, and that persistent high-risk-type infection can progress to cancer.. HPV causes roughly 39,300 cancers a year in the United States, the large majority arising from persistent high-risk infections rather than the many infections that clear 2Ref 2Centers for Disease Control and Prevention (2024).Basic Information about HPV and Cancer.Supports that HPV causes roughly 39,300 cancers a year in the U.S., primarily cervical cancer in women and oropharyngeal cancer in men, used here to describe the outcome of persistent high-risk infection..

Persistence is defined by time, not sensation — there is no symptom that distinguishes a persisting infection from one about to clear, which is exactly why screening rather than symptom-watching is how persistence gets caught.

What does "clearing" actually mean?

Clearing an HPV infection means the immune system suppresses the virus to undetectable levels, generally within one to two years, and most people who clear an infection never develop any symptom or abnormal test result related to it. It does not require any treatment, medication, or specific behavior — the process runs on its own timeline.

Because there is no treatment that clears the virus itself — only the warts, precancerous cells, or other effects it can cause are treated when they appear — there is nothing a person can take or do to speed up clearance beyond what the immune system is already doing. That can be a hard thing to hear for someone who wants to actively fix the situation, but it is also, in most cases, reassuring: the infection resolves without any intervention far more often than not 1Ref 1Centers for Disease Control and Prevention (2024).Human Papillomavirus (HPV).Supports that HPV is the most common STI in the U.S., that most infections clear on their own, and that persistent high-risk-type infection can progress to cancer..

What happens when HPV persists?

A persistent high-risk HPV infection is the step that precedes most HPV-related cancer, but persistence itself typically takes years to progress to anything serious, and regular cervical cancer screening exists specifically to catch changes during that long window rather than after cancer has developed 2Ref 2Centers for Disease Control and Prevention (2024).Basic Information about HPV and Cancer.Supports that HPV causes roughly 39,300 cancers a year in the U.S., primarily cervical cancer in women and oropharyngeal cancer in men, used here to describe the outcome of persistent high-risk infection.. Persistence with a low-risk type, by contrast, is more likely to show up as genital warts than as a cancer risk.

There is currently no approved routine HPV test for men the way there is for cervical screening in women, which is why hpv testing in men is a genuinely different situation from the female side of this. Persistence in men is generally tracked through visible effects like warts, or in some cases through screening for related cancers, rather than through a direct test for the virus itself.

Vaccination and preventing new infections

HPV vaccination does not clear an existing infection, but it prevents infection with the HPV types included in the vaccine, which is why routine vaccination at ages 11 to 12 — with catch-up vaccination through age 26 — is recommended before most people are exposed 3Ref 3Centers for Disease Control and Prevention (Advisory Committee on Immunization Practices) (2024).ACIP Recommendations: Human Papillomavirus (HPV) Vaccine.Supports the U.S. HPV vaccination recommendation of routine vaccination at ages 11-12, catch-up through age 26, and shared clinical decision-making for adults 27-45.. Vaccination for adults 27 to 45 is available through shared clinical decision-making for those who may still benefit from protection against types they have not yet acquired.

Because a new HPV infection with a different type is possible even after a prior infection has cleared, vaccination remains relevant for many adults who are already sexually active, not only for those who have never been exposed to the virus at all.

The vaccine works by preventing new infection with the types it covers; it has no effect on an infection someone already has at the time they're vaccinated. That distinction is part of why the vaccine is recommended as early as possible — it protects against exposures that haven't happened yet, not ones that already have.

Does condom use affect clearance or reinfection risk?

Condoms reduce the risk of getting or transmitting HPV, but they do not fully prevent it, because HPV spreads through skin-to-skin contact in areas a condom does not necessarily cover 4Ref 4Centers for Disease Control and Prevention (2024).Condom Use: An Overview.Supports that condoms offer only partial protection against infections spread by skin-to-skin contact, such as HPV, compared to more complete protection against fluid-borne infections.. Condom use has no effect on how a current infection resolves, but it can lower the chance of acquiring a new infection with a different HPV type going forward.

That partial protection is a common source of confusion, since condoms are highly effective against infections spread through genital fluids. HPV simply behaves differently, which is why vaccination and screening carry more of the preventive weight for this particular infection than barrier methods alone.

How is persistence actually tracked?

Persistence is tracked through routine cervical cancer screening — repeat Pap tests, HPV tests, or both, spaced out over years — rather than through a test that checks for the virus on its own outside of that context. A single positive HPV result is common and, by itself, does not mean much.

What matters clinically is whether the same high-risk type is still detected at a follow-up screening a year or more later, which is why screening intervals matter as much as any single result. Skipping the follow-up screening after a positive result is a more common way persistence goes unnoticed than the initial result itself being missed.

This is also why a single abnormal result rarely leads straight to treatment. Clinicians generally want to see whether an abnormality persists or resolves across more than one screening interval before deciding that further evaluation, rather than continued monitoring, is the right next step.